Introducing the intergroup 0116 protocol of adjuvant chemo-radiotherapy in gastric cancer into clinical practice

Clinical Oncology

Volumn 15, Issue 7, 2003, Pages 378-382

  Back, M F ^a   Premsenthil, S ^a   Wynne, C J ^a   Shakespeare, T P ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Gastric cancer; Quality assurance; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL TOXICITY; HEALTH CARE QUALITY; HOSPITAL ADMISSION; HUMAN; LIVER HILUS; MALE; MEDICAL AUDIT; MEDICAL RECORD; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION DOSE; REPRODUCIBILITY; SINGAPORE; STOMACH CANCER; UNITED STATES; UNIVERSITY HOSPITAL; WEIGHT REDUCTION;

EID: 0141854234     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0936-6555(03)00154-7     Document Type: Article

References (17)

1. Macdonald J, Smalley S, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach and gastroesophageal junction. N Engl J Med 2001; 345:725-730.
2. Hermans J, Bonenkamp JJ, Boon MC, et al. Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol 1993;11:1441-1447.
3. Coombes RC, Schein PS, Chilvers CE, et al. A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group. J Clin Oncol 1990;8:1362-1369.
4. Songun I, Keizer HJ, Hermans J, et al. Chemotherapy for operable gastric cancer: results of the Dutch randomised FAMTX trial. The Dutch Gastric Cancer Group (DGCG). Eur J Cancer 1999; 35:558-562.
5. Macdonald J, Smalley S, Brown T, et al. Phase III Intergroup Trial of Adjuvant Chemoradiation after gastric resection for adenocarcinoma. NCI High Priority Study INT 0116. Edition April 20, 1998.
6. Smalley SR, Gunderson L, Tepper J, et al. Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation. Int J Radiat Oncol Biol Phys 2002;52:283-293.
7. Kajitani T. Japanese Research Society for Gastric Cancer: the general rules for the gastric cancer study in surgery and pathology. Part I clinical classification. Jpn J Surg 1981;11:127-139.
8. TROG quality assurance statement of minimum requirements for clinical trials. Trans-Tasman Radiation Oncology Group handbook. Newcastle, Australia; 1999:9-10.
9. Back M, Delaney G, Denham J, et al. How should we introduce high-dose chemotherapeutic strategies into the adjuvant management of high-risk breast cancer in Australasia? Aust N Z J Surg 1998;68:10-15.
10. Dicato M. High-dose chemotherapy in breast cancer: where are we now? Semin Oncol 2002;29(suppl 8):16-20.
11. Piccart MJ, Lohrisch C, Duchateau L, et al. Taxanes in the adjuvant treatment of breast cancer: why not yet? J Natl Cancer Inst Monogr 2001;30:88-95.
12. Regine WF, Mohiuddin M. Impact of adjuvant therapy on locally advanced adenocarcinoma of the stomach. Int J Radiat Oncol Biol Phys 1992;24:921.
13. Degirmenci B, Uysal K, Bekis R, et al. Tc-99m MDP, thallium-201 chloride and Tc-99m MAG3 renal uptake in subacute and chronic radiation nephritis compared. Ann Nucl Med 2001;15:447-449.
14. Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Br J Cancer 1999;79:1422.
15. Sakamoto J, Yasue M. Extensive lymphadenectomy for gastric cancer patients: what can the results of one trial tell us? Lancet 1995;345:742-743.
16. Radiation Therapy Oncology Group Philadelphia. Study Protocol radiotherapyOG G-0114. A randomized phase II comparison of two cisplatin-paclitaxel containing chemoradiation regimens in resected gastric cancers.
17. Hermanek P, Hermanek PJ. Role of the surgeon as a variable in the treatment of rectal cancer. Semin Surg Oncol 2000;19:329-335.